Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases

Role of Oxidative Stress in Blood–Brain Barrier Disruption and Neurodegenerative Diseases

Upregulation of reactive oxygen species (ROS) levels is a principal feature observed in the brains of neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). In these diseases, oxidative stress can disrupt the blood–brain barrier (BBB). This disruption allows neurot...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Antioxidants
Subjects:	neurodegenerative diseases reactive oxygen species oxidative damage blood–brain barrier blood-derived protein
Online Access:	https://www.mdpi.com/2076-3921/13/12/1462
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Elucidation of Contemporary Brain Targeting Tactics Employed in the Treatment of Neurodegenerative Diseases
by: Authman M. Alsamarrai, et al.
Published: (2023-12-01)

Polymerase delta-interacting protein 2 mediates brain vascular permeability by regulating ROS-mediated ZO-1 phosphorylation and localization at the interendothelial border
by: Keke Wang, et al.
Published: (2025-01-01)

Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases
by: Francisco J. Garcia, et al.
Published: (2025-01-01)

Breaking boundaries: role of the brain barriers in metastatic process
by: Nasim Izadi, et al.
Published: (2025-01-01)

Ginsenoside Rg1 Alleviates Blood–Milk Barrier Disruption in Subclinical Bovine Mastitis by Regulating Oxidative Stress-Induced Excessive Autophagy
by: Shanshan Yang, et al.
Published: (2024-11-01)

MicroRNA-155 modulates methotrexate-induced spatial memory impairment by disruption of the blood-brain barrier integrity
by: Yu-Chieh Chen, et al.
Published: (2025-03-01)

Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases
by: Lin Xu, et al.
Published: (2025-01-01)

Oxidative Stress in the Pathogenesis of Neurodegenerative Diseases
by: Maria-Carolina Jurcau, et al.
Published: (2024-12-01)

The Effects of Glutathione Monoethyl Ester on Different Biochemical, Oxidant, and Antioxidant Levels During Storage in Leukoreduced Red Blood Cells
by: Behrooz Ghezelbash, et al.
Published: (2024-11-01)

Mimicking Marker Spread After Disruption of the Blood–Brain Barrier with a Collagen-Based Hydrogel Phantom
by: Anastasia S. Vanina, et al.
Published: (2024-11-01)

Overcoming the Blood–Brain Barrier: Multifunctional Nanomaterial‐Based Strategies for Targeted Drug Delivery in Neurological Disorders
by: Callan D. McLoughlin, et al.
Published: (2024-12-01)

Mannitol and the blood-labyrinth barrier
by: Trung N. Le, et al.
Published: (2017-12-01)

Pterostilbene protects against lipopolysaccharide-induced inflammation and blood–brain barrier disruption in immortalized brain endothelial cell lines in vitro
by: Yan Zhou, et al.
Published: (2025-01-01)

Nanotherapeutics for Meningitis: Enhancing Drug Delivery Across the Blood-Brain Barrier
by: Hitaishi Sharma, et al.
Published: (2025-01-01)

Oxidative modulations in platelets stored in SSP+, PAS-G and Tyrode's buffer: a comparative analysis
by: Magdaline Christina Rajanand, et al.
Published: (2024-11-01)

Mechanism of the blood-brain barrier modulation by cadherin peptides
by: Elinaz Farokhi, et al.
Published: (2024-06-01)

Polystyrene nanoplastics promote the blood-brain barrier dysfunction through autophagy pathway and excessive erythrophagocytosis
by: Eun-Hye Kim, et al.
Published: (2025-01-01)

Infection with Toxoplasma gondii triggers coagulation at the blood-brain barrier and a reduction in cerebral blood flow
by: Evelyn M. Hoover, et al.
Published: (2025-01-01)

Chemokine associations with blood cerebrospinal fluid (CSF) barrier permeability and delirium
by: Paul Denver, et al.
Published: (2025-02-01)

Albumin-seeking near-infrared-II probe evaluating blood–brain barrier disruption in stroke
by: Hong-Jing Zhu, et al.
Published: (2024-11-01)

Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage
by: Daniel Ullrich, et al.
Published: (2025-02-01)

Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by Toxoplasma gondii infection
by: Zihan Yang, et al.
Published: (2024-12-01)

Serum detection of blood brain barrier injury in subjects with a history of stroke and transient ischemic attack
by: Scott French, et al.
Published: (2024-01-01)

A four-channel microfluidic model of the blood–brain and blood–cerebrospinal fluid barriers: fluid dynamics analysis
by: Pavel A. Libet, et al.
Published: (2024-12-01)

Overexpression of endothelial S1pr2 promotes blood–brain barrier disruption via JNK/c-Jun/MMP-9 pathway after traumatic brain injury in both in vivo and in vitro models
by: Hongbo Cheng, et al.
Published: (2024-11-01)

Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood–brain barrier
by: Joanna R. Thomas, et al.
Published: (2024-03-01)

Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study
by: L. M. Maboko, et al.
Published: (2024-12-01)

Feedback loop centered on MAF1 reduces blood–brain barrier damage in sepsis-associated encephalopathy
by: Xuebiao Wei, et al.
Published: (2025-01-01)

A new frontier in neuropharmacology: Recent progress in natural products research for blood–brain barrier crossing
by: Ureña-Vacas Isabel, et al.
Published: (2024-01-01)

Blood-brain barrier disruption and increased free water are associated with worse cognitive performance in patients with chronic cerebrovascular disease
by: Kyle C. Kern, et al.
Published: (2024-01-01)

Brain-targeting drug delivery systems: The state of the art in treatment of glioblastoma
by: Bo Sun, et al.
Published: (2025-02-01)

Research Progress in Effects of Gut Microbiota and Their Metabolites on the Blood-brain Barrier and Interventions by Probiotics
by: Qiqi DONG, et al.
Published: (2024-11-01)

Delivering therapeutic RNA into the brain using extracellular vesicles
by: Paniz Shirmast, et al.
Published: (2024-12-01)

Iron induces blood-brain barrier alteration contributing to cognitive impairment in β-thalassaemia mice
by: Parinda Jamrus, et al.
Published: (2025-01-01)

Senolytic therapy preserves blood-brain barrier integrity and promotes microglia homeostasis in a tauopathy model
by: Minmin Yao, et al.
Published: (2024-11-01)

5-Hydroxytryptophan artificial synaptic vesicles across the blood-brain barrier for the rapid-acting treatment of depressive disorder
by: Peng Chang, et al.
Published: (2024-12-01)

The molecular mechanisms by which the NLRP3 inflammasome regulates blood-brain barrier permeability following cryptococcal meningitis
by: Lingjuan Liu, et al.
Published: (2024-12-01)

Isolation method of brain microvessels from small frozen human brain tissue for blood-brain barrier protein expression analysis
by: Seiryo Ogata, et al.
Published: (2024-12-01)

The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood–brain barrier protection
by: Jia-Cheng Liu, et al.
Published: (2024-12-01)

Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
by: Jonathan G. Pol, et al.
Published: (2024-12-01)